Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Condition: Advanced Endometrial Cancer, Sarcoma of Uterus
NCT05481645
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.